Skip to main content
Premium Trial:

Request an Annual Quote

Foundation Medicine Partners with Sanofi to Identify Biomarkers for Cancer Drugs

Premium

Foundation Medicine said this week that is has inked a strategic collaboration with Sanofi for cancer biomarkers.

Under the agreement, the Cambridge, Mass.-based company will use its genomic sequencing and analysis expertise to identify genetic biomarkers and potential companion diagnostics for certain oncology drug candidates from Sanofi.

The partnership with Sanofi adds to four other collaborations Foundation has established with pharmaceutical firms, including Johnson & Johnson Pharmaceutical Research and Development, Novartis, and Celgene.

In addition to these alliances, Foundation Medicine is working on a diagnostic cancer genomic test, which uses next-generation sequencing to analyze about 200 cancer-related genes in clinical-grade tumor tissues (CSN 6/8/2011).

Last fall, the company raised $33.5 million in a Series A financing round to support the commercialization of the test, which it plans to launch in the second quarter of this year.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.